Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NVSEF - Novartis Q2 Struck By Deferrable Portfolio Elements But Pipeline Continues To Develop


NVSEF - Novartis Q2 Struck By Deferrable Portfolio Elements But Pipeline Continues To Develop

By Guney Kaya

Novartis (NVS) has been a key pick for us during the coronavirus pandemic. Although a quintessential biopharma company, it has one of the safest pipelines with dozens of therapies already in registration phase or phase III. Their strategic shift to being a more value-add and innovation-based pharma company has borne fruit, with many of their recent therapies, such as Cosentyx and Entresto, driving a large portion of their sales. Their dividend is also attractive, yielding 3.68%, which is on the higher side for a growth-based business, lower only than the

Read more ...

Stock Information

Company Name: Novartis Ag Basel Akt
Stock Symbol: NVSEF
Market: OTC
Website: novartis.com

Menu

NVSEF NVSEF Quote NVSEF Short NVSEF News NVSEF Articles NVSEF Message Board
Get NVSEF Alerts

News, Short Squeeze, Breakout and More Instantly...